Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:605077's Forward Dividend Yield % is ranked better than 87.19% of 1023
companies
in the Chemicals industry
Industry Median: 1.71
vs SHSE:605077: 4.56
During the past 3 years, the average Dividends Per Share Growth Rate was 14.90% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Zhejiang Huakang Pharmaceutical Co was 21.30% per year. The lowest was 14.90% per year. And the median was 18.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zhejiang Huakang Pharmaceutical Co Forward Dividend Yield % Related Terms
SHSE:605077 vs DOW: Forward Dividend Yield % Comparison
For the Chemicals subindustry, Zhejiang Huakang Pharmaceutical Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Huakang Pharmaceutical Co Forward Dividend Yield % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Zhejiang Huakang Pharmaceutical Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Zhejiang Huakang Pharmaceutical Co's Forward Dividend Yield % falls into.
Zhejiang Huakang Pharmaceutical Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Zhejiang Huakang Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.300000
2026-06-17
2026-06-16
2026-06-17
Cash Dividend
semi-annually
CNY:CNY 1.000000
CNY 0.200000
2025-09-29
2025-09-26
2025-09-29
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 4.56% mean?
Zhejiang Huakang Pharmaceutical Co (SHSE:605077) has a Forward Dividend Yield % of 4.56% as of Jul. 30, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. According to the industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #131 out of 1023 companies in the Chemicals industry, placing it in the top 12.8%.
Is Zhejiang Huakang Pharmaceutical Co's Forward Dividend Yield % too high?
Zhejiang Huakang Pharmaceutical Co's current Forward Dividend Yield % is 4.56%. The Chemicals industry median Forward Dividend Yield % is 1.71. Zhejiang Huakang Pharmaceutical Co's value of 4.56% is 166.7% above this industry median. Based on the distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #131 out of 1023 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Huakang Pharmaceutical Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Huakang Pharmaceutical Co's Forward Dividend Yield % compare to DOW?
According to the Chemicals industry distribution chart, Zhejiang Huakang Pharmaceutical Co ranks #131 out of 1023 companies for Forward Dividend Yield %. This places Zhejiang Huakang Pharmaceutical Co in the top 13% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 1.71. Zhejiang Huakang Pharmaceutical Co's value of 4.56% is 166.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Chemicals company?
The median Forward Dividend Yield % among Chemicals companies is 1.71, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Huakang Pharmaceutical Co's current Forward Dividend Yield % of 4.56% is 166.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zhejiang Huakang Pharmaceutical Co and its competitors. For the Chemicals industry, the median Forward Dividend Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Huakang Pharmaceutical Co's current Forward Dividend Yield % is 4.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Huakang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co (SHSE:605077) is currently considered Possible Value Trap. The stock's GF Value™ is ¥39.70, compared to a current price of ¥10.90 — trading 72.5% below its estimated fair value. The current Forward Dividend Yield % is 4.56% and 166.7% above the Chemicals industry median of 1.71. Zhejiang Huakang Pharmaceutical Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Zhejiang Huakang Pharmaceutical Co (SHSE:605077), the current Forward Dividend Yield % is 4.56% as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Huakang Pharmaceutical Co (SHSE:605077) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Huakang Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥10.90 is trading 72.5% below its estimated GF Value™ of ¥39.70.
GuruFocus considers Zhejiang Huakang Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for SHSE:605077:
Forward Dividend Yield %: 4.56%
GF Value™: ¥39.70 vs. price of ¥10.90 (72.5% below fair value)
Industry Position: 166.7% above the Chemicals median (#131 of 1023)
No single metric tells the full story. See the SHSE:605077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Huakang Pharmaceutical Co Business Description
Zhejiang Huakang Pharmaceutical Co Ltd is engaged in the research and development, production and sales of various functional sugar alcohols and starch sugar products such as xylitol, sorbitol, maltitol, fructose syrup and others.
74GF Score
Get the complete analysis for SHSE:605077
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605077 has been successfully added to your 
